Colloidal gold-based rapid test for simultaneous detection of dengue-specific antibodies and NS1 antigen. Enables early-stage and acute dengue infection diagnosis.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Neo-nostics (Suzhou) Bioengineering Co., Ltd
China · 3 relevant products
Coei Biotech
China · 1 relevant product
Lumigenex (Suzhou) Co., Ltd
China · 4 relevant products
DASKY
China · 2 relevant products
Nanjing Norman Biological Technology Co., Ltd.
China · 2 relevant products
Guangdong Ardent BioMed Co., Ltd.
China · 1 relevant product
YASEE BioMedical Inc.
China · 1 relevant product
Guangzhou Labsim Medical Diagnostics Co., Ltd.
China · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Hangzhou Realy Tech Co., Ltd
China · 3 relevant products
55 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →4 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 117 closest product alternatives
Neo-nostics (Suzhou) Bioengineering Co., Ltd · China
Rapid diagnostic test kit for simultaneous detection of dengue IgG, IgM, and NS1 antigen using colloidal gold immunochromatographic method. Designed for point-of-care diagnosis of dengue fever infection with results available within 15-20 minutes. Suitable for clinical laboratories, hospitals, and field testing in endemic regions.
Coei Biotech · China
Dengue virus NS1 antigen detection kit utilizing colloidal gold immunochromatographic technology for rapid point-of-care diagnosis. Enables early detection of dengue infection during the acute phase with high sensitivity. Designed for clinical laboratories and healthcare facilities requiring efficient dengue screening capabilities.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting both SARS-CoV-2 and Influenza A+B antigens in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for simultaneous COVID-19 and influenza diagnosis.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting SARS-CoV-2 IgG and IgM antibodies in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for COVID-19 serology testing.
DASKY · China
Immunochromatographic rapid test utilizing colloidal gold particles for qualitative detection. Provides quick results for various diagnostic applications.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting SARS-CoV-2 neutralizing antibodies in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for assessing immune response to SARS-CoV-2.
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting SARS-CoV-2 antigen in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for COVID-19 diagnosis.
Nanjing Norman Biological Technology Co., Ltd. · China
Rapid point-of-care diagnostic test utilizing colloidal gold detection technology for qualitative or semi-quantitative results. Available for multiple disease targets including infectious disease detection.
Guangdong Ardent BioMed Co., Ltd. · China
Rapid antigen detection kit for SARS-CoV-2 using colloidal gold immunochromatography. Delivers qualitative results for COVID-19 diagnosis in clinical and point-of-care settings. Designed for swift patient screening and laboratory confirmation protocols.
YASEE BioMedical Inc. · China
Point-of-care immunoassay test utilizing colloidal gold technology for rapid detection and diagnosis in clinical laboratory and emergency settings.
Guangzhou Labsim Medical Diagnostics Co., Ltd. · China
A rapid test kit for the detection of SARS-CoV-2 antigens using colloidal gold technology. This kit enables rapid point-of-care testing for COVID-19 detection.
Guangzhou Wondfo Biotech Co., Ltd. · China
Colloidal gold-based rapid immunoassay test for point-of-care diagnostics. Delivers fast qualitative or quantitative results with high sensitivity and specificity. Ideal for clinical laboratories and decentralized testing environments requiring reliable disease detection and screening.
105 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products